EUVIMEDObjevte EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Association of the FGF4L2 retrogene with fibrocartilaginous embolic myelopathy in dogs

Colleen Embersics, Danika Bannasch iD, Kevin Batcher, Elizabeth C Boudreau iD, Molly Church, Andrew Miller, Simon Platt iD, Jey Koehler, Natasha Olby iD, John Rossmeisl iD, Daniel Rissi, Robert Grahn and 2 more

Journal of Veterinary Internal Medicine · 2024-01-01 · 38 (1) · 258-267

DOI: 10.1111/jvim.16925 ↗

At a glance

Multizentrische Studie in Journal of Veterinary Internal Medicine, published online on 2024-01-01. Written by Colleen Embersics and 13 co-authors. Institution: Veterinary Medical Teaching Hospital, UC Davis School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Major MEDLINE topics: Cartilage Diseases, Dog Diseases, Embolism, Spinal Cord Diseases. Cited 3 times so far (Crossref); 85 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Center for Companion Animal Health, University of California, Davis.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Fibrocartilaginous embolic myelopathy (FCE) is a well-documented condition in dogs although rarely reported in chondrodystrophic breeds. Genetic associations have not been defined.

Objectives

Define the association of the chondrodystrophy-associated FGF4L2 retrogene with histopathologically confirmed cases of FCE. Animals Ninety-eight dogs with a histopathologic diagnosis of FCE.

Methods

Retrospective multicenter study. Dogs were genotyped for the FGF4L2 and FGF4L1 retrogenes using DNA extracted from formalin-fixed, paraffin-embedded tissue. Associations between breed, FCE and retrogene status were investigated with reference to a hospital population and known breed and general population allele frequencies.

Results

FGF4L2 genotype was defined in 89 FCE cases. Fibrocartilaginous embolic myelopathy was present in 22 dogs from FGF4L2-segregating breeds with allele frequencies of ≥5%; however, all dogs were wild type. Two Labrador retrievers with FCE carried FGF4L2 alleles. Frequency of the FGF4L2 allele was significantly (P < .001) and negatively associated with FCE relative to predicted hospital-population dogs. FCE was overrepresented in Boxer, Great Dane, Yorkshire Terrier, Bernese Mountain Dog, Miniature Schnauzer, Rottweiler, and Shetland Sheepdog breeds. Conclusions and Clinical Importance Study data based on genotypically and histopathologically defined cases support the historical observation that FCE is uncommon in chondrodystrophic dog breeds. FGF4 plays an important role in angiogenesis and vascular integrity; anatomical studies comparing chondrodystrophic and non-chondrodystrophic dogs might provide insight into the pathogenesis of FCE.

Subjects

MeSH terms (MEDLINE)

Cartilage DiseasesDog DiseasesEmbolismSpinal Cord DiseasesAnimalsDogsGenotype

Author keywords

FCEcaninechondrodystrophyfibroblast growth factor

Authors and institutions

  • Veterinary Medical Teaching Hospital, UC Davis School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Department of Population Health and Reproduction, University of California, Davis, Davis, California, USA.
  • Department of Small Animal Clinical Sciences, Texas A&M School of Veterinary Medicine & Biomedical Sciences, College Station, Texas, USA.
  • Department of Pathobiology, University of Pennsylvania, School of Veterinary Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical Sciences, Cornell University College of Veterinary Medicine, Ithica, New York, USA.
  • Vetoracle Teleneurology, Athens, Georgia, USA.

ORCID profiles: Danika Bannasch, Elizabeth C Boudreau, Simon Platt, Natasha Olby, John Rossmeisl, Peter J Dickinson

Funding

  • Center for Companion Animal Health, University of California, Davis

Cite

APA

Embersics, C., Bannasch, D., Batcher, K., Boudreau, E. C., Church, M., Miller, A., Platt, S., Koehler, J., Olby, N., Rossmeisl, J., Rissi, D., Grahn, R., Donner, J., & Dickinson, P. J. (2024). Association of the FGF4L2 retrogene with fibrocartilaginous embolic myelopathy in dogs. Journal of Veterinary Internal Medicine, 38(1), 258-267. https://doi.org/10.1111/jvim.16925

Vancouver

Embersics C, Bannasch D, Batcher K, Boudreau EC, Church M, Miller A, et al. Association of the FGF4L2 retrogene with fibrocartilaginous embolic myelopathy in dogs. Journal of Veterinary Internal Medicine. 2024;38(1):258-267. doi:10.1111/jvim.16925

BibTeX
@article{Embersics2024,
  author = {Embersics, Colleen and Bannasch, Danika and Batcher, Kevin and Boudreau, Elizabeth C and Church, Molly and Miller, Andrew and Platt, Simon and Koehler, Jey and Olby, Natasha and Rossmeisl, John and Rissi, Daniel and Grahn, Robert and Donner, Jonas and Dickinson, Peter J},
  title = {Association of the FGF4L2 retrogene with fibrocartilaginous embolic myelopathy in dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {1},
  pages = {258--267},
  doi = {10.1111/jvim.16925}
}
Start for free →